Business
Who will be next to implement an Australia-style under-16s social media ban?
Recently the Australian Senate passed a law to ban children under 16 from having social media accounts including TikTok, Facebook, Snapchat, Reddit, X. Matt Cardy | Getty Images News | Getty Images Australia’s social media ban for under-16s has grabbed global attention, and governments worldwide are considering implementing similar policies, with the U.K. seen as […]
Read More
Musk seeks up to $134 billion from OpenAI and Microsoft in ‘wrongful gains’
Elon Musk, chief executive officer of Tesla Inc., during the US-Saudi Investment Forum at the Kennedy Center in Washington, DC, US, on Wednesday, Nov. 19, 2025. Bloomberg | Bloomberg | Getty Images Elon Musk is seeking up to $134 billion from OpenAI and Microsoft, saying he deserves the “wrongful gains” that they received from his […]
Read More
Disney dominated the 2025 box office. Here’s how it could keep the crown in 2026
Courtesy of Disney Enterprises Inc. Blue aliens, a family of superheroes and a city of talking animals boosted the Walt Disney Company to the top of the domestic box office in 2025. Full-year ticket sales in the United States and Canada rose about 4% from 2024 to $9.05 billion. Disney accounted for the highest share […]
Read More
Big earnings reports and worries around the interest rate outlook could sway markets next week
Company earnings and what happens with the interest rate outlook will unlock what’s next for a broadening stock market. Stocks are headed for a down week following an uneven start to the fourth-quarter earnings season. Of the big banks that kick off the reporting period, the retail banking players — JPMorgan, Citigroup, Bank of America, […]
Read More
Micron stock climbs as CEO highlights AI demand for memory
Micron stock rose 6% Friday as investors looked to buy AI chip supply chain stocks after Taiwan Semiconductor Manufacturing Company reported robust earnings on Thursday, signaling continued AI infrastructure spending. Shares of Micron, one of the makers of memory and storage for artificial intelligence systems, are up 52% over the last month, as memory is […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]
Read More
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company’s new GLP-1 pill […]
Read More
ASML hits record high on AI boost — and analysts see plenty of room to run
A logo on the exterior of the ASML Holding NV headquarters in Veldhoven, Netherlands, on Wednesday, Jan. 24, 2024. Peter Boer | Bloomberg | Getty Images Dutch semiconductor equipment company ASML has held gains to hit record highs, following Taiwanese chipmaker TSMC’s strong earnings report on Thursday. ASML — Europe’s most valuable company and the […]
Read More
AI chip trade, Saks’ bankruptcy woes, Trump’s health-care plan and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Friday. This week isn’t even over yet, but I’m already gearing up for next week’s big events: the World Economic Forum in Davos, a major Supreme Court case and Netflix earnings. S&P 500 futures are higher this morning after yesterday’s winning […]
Read More
Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more
Check out the companies making headlines before the bell. ImmunityBio — The biotech company rallied 22%, adding to a 30% rally in the previous session that was sparked by strong guidance for its bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to jump 700%. Coupang — Shares rose more than 3% after […]
Read More